Abstract
Cardiac health depends on the heart’s ability to utilize different substrates to support overall oxidative metabolism. To characterize a variety of cardiac diseases, there is an ever-growing demand for an accurate non-invasive approach to evaluating myocardial substrate metabolism. Data obtained from quantitative metabolic imaging modalities add functional information to the anatomic imaging modalities and can aid patient management.
The goal of this review is to emphasize the role of non-invasive imaging techniques (such as PET, SPECT, MR spectroscopy and spectroscopic imaging) to detect the metabolic footprints of heart disease. The advancements of models and methods to estimate kinetic parameters of dynamic processes using data acquired from cardiac imaging modalities is discussed.
Keywords: Positron emission tomography, single photon emission computed tomography, magnetic resonance spectroscopy, magnetic resonance spectroscopic imaging, cardiac metabolism, metabolic imaging, compartmental models, kinetic models, kinetic parameter estimation and fitting.
Current Pharmaceutical Design
Title:Models and Methods in Cardiac Imaging for Metabolism Studies
Volume: 20 Issue: 39
Author(s): Santarelli M.F., Martini N., Positano P. and Landini L.
Affiliation:
Keywords: Positron emission tomography, single photon emission computed tomography, magnetic resonance spectroscopy, magnetic resonance spectroscopic imaging, cardiac metabolism, metabolic imaging, compartmental models, kinetic models, kinetic parameter estimation and fitting.
Abstract: Cardiac health depends on the heart’s ability to utilize different substrates to support overall oxidative metabolism. To characterize a variety of cardiac diseases, there is an ever-growing demand for an accurate non-invasive approach to evaluating myocardial substrate metabolism. Data obtained from quantitative metabolic imaging modalities add functional information to the anatomic imaging modalities and can aid patient management.
The goal of this review is to emphasize the role of non-invasive imaging techniques (such as PET, SPECT, MR spectroscopy and spectroscopic imaging) to detect the metabolic footprints of heart disease. The advancements of models and methods to estimate kinetic parameters of dynamic processes using data acquired from cardiac imaging modalities is discussed.
Export Options
About this article
Cite this article as:
M.F. Santarelli, N. Martini, P. Positano and L. Landini, Models and Methods in Cardiac Imaging for Metabolism Studies, Current Pharmaceutical Design 2014; 20 (39) . https://dx.doi.org/10.2174/1381612820666140417114122
DOI https://dx.doi.org/10.2174/1381612820666140417114122 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Heart Failure in Sub-Saharan Africa
Current Cardiology Reviews Testosterone and Cardioprotection Against Myocardial Ischemia
Cardiovascular & Hematological Disorders-Drug Targets QT Prolongation and Safety in the Indian Population
Current Drug Safety Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Mitochondrially Targeted Antioxidants for the Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Endothelial Dysfunction in Metabolic Diseases: Role of Oxidation and Possible Therapeutic Employment of N-acetylcysteine
Current Medicinal Chemistry “Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease
Current Vascular Pharmacology Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes
Current Pharmaceutical Design Dietary Carbohydrates that Modulate the Immune System
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line
Recent Patents on Anti-Cancer Drug Discovery Acute Cerebral Blood Flow Variations after Human Cardiac Arrest Assessed by Stable Xenon Enhanced Computed Tomography
Current Neurovascular Research Patent Selections
Recent Patents on Biomarkers Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
Current Pharmaceutical Design Patterns of Self-Medication with Medicinal Plants and Related Adverse Events - A South American Survey
Current Drug Safety A Comprehensive Review on Chrysin: Emphasis on Molecular Targets, Pharmacological Actions and Bio-pharmaceutical Aspects
Current Drug Targets Functional Variants of the Interleukin-23 Receptor Gene in Non-Gastrointestinal Autoimmune Diseases
Current Medicinal Chemistry Role of the Wnt/β-Catenin Pathway in the Pathogenesis of Alcoholic Liver Disease
Current Molecular Pharmacology Editorial from Guest Editor [Hot topic: Novel Inflammatory Biomarkers in Diseases (Guest Editor: Yu Chen)]
Inflammation & Allergy - Drug Targets (Discontinued) Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
Letters in Drug Design & Discovery Determination of Stimulants and Diuretics in Dietary Supplements for Weight Loss and Physical Fitness by Ion-pair Chromatography and Pulsed Amperometric Detection (PAD)
Current Analytical Chemistry